Clinical Trials Directory

Trials / Conditions / Recurrent Ovarian Clear Cell Adenocarcinoma

Recurrent Ovarian Clear Cell Adenocarcinoma

8 registered clinical trials studyying Recurrent Ovarian Clear Cell Adenocarcinoma — 3 currently recruiting.

StatusTrialSponsorPhase
WithdrawnTesting the Addition of ASTX660 (Tolinapant) to the Usual Chemotherapy Treatment (Paclitaxel With or Without B
NCT06393751
National Cancer Institute (NCI)Phase 1 / Phase 2
RecruitingPembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patien
NCT05231122
Roswell Park Cancer InstitutePhase 2
RecruitingTesting Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovaria
NCT05950464
National Cancer Institute (NCI)Phase 1
RecruitingVaccine Therapy Plus Pembrolizumab in Treating Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cavity
NCT05920798
Mayo ClinicPhase 1 / Phase 2
Active Not RecruitingComparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic Agents
NCT04739800
National Cancer Institute (NCI)Phase 2
Active Not RecruitingA Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With
NCT04092270
National Cancer Institute (NCI)Phase 1
Active Not RecruitingTazemetostat in Treating Patients With Recurrent Ovarian or Endometrial Cancer
NCT03348631
National Cancer Institute (NCI)Phase 2
Active Not RecruitingPegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With R
NCT02839707
National Cancer Institute (NCI)Phase 2 / Phase 3